Colorectal cancer Posts on Medivizor
Navigation Menu

Colorectal cancer Posts on Medivizor

A combination of FOLFOXIRI and targeted therapy in the treatment of advanced colorectal cancer

Posted by on Oct 17, 2017 in Colorectal cancer | 0 comments

In a nutshell This study examined the effectiveness of FOLFOXIRI combined with targeted therapy (TT) in advanced colorectal cancer. This study concluded that FOLFOXIRI plus TT was associated with better outcomes compared to other treatment combinations. Some background Chemotherapy is used to reduce symptoms and increase survival in colorectal...

Read More

If Not For Immunotherapy…

If Not For Immunotherapy…

Posted by on Oct 10, 2017 in Blog, Colorectal cancer | 0 comments

“I’m barely 27 and if it were not for immunotherapy and cancer research, I would not have seen 25.”  So starts Stefanie Joho speech at a 2017 Congressional Hearing called “Progress in Immunotherapy: Delivering Hope and Clinical Benefit to Cancer Patients.” When Stefanie was 22, she was diagnosed with a very aggressive Stage II...

Read More

Is chemoradiation with local removal, better than total surgical removal to treat stage II rectal cancer?

Posted by on Sep 29, 2017 in Colorectal cancer | 0 comments

In a nutshell This study looked survival rates of stage II rectal cancer patients who underwent different treatments. It compared radical surgery versus local excision with added-on chemoradiation. The article concluded that overall survival was not different between the treatments. Some background Radical surgery (RS – complete...

Read More

Post-surgery complications can affect chemotherapy treatment after surgery in colorectal cancer

Posted by on Sep 28, 2017 in Colorectal cancer | 0 comments

In a nutshell This study investigated the post-surgery factors that affect the use of chemotherapy after surgery in colorectal cancer patients. Researchers suggested that post-surgery complications are associated with delay or not receiving chemotherapy treatment.   Some background Surgery and post-surgery chemotherapy are the standard...

Read More

Can Video Gaming Build Resilience? You Decide…

Can Video Gaming Build Resilience?   You Decide…

Posted by on Sep 20, 2017 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer, Rheumatoid Arthritis, Stroke | 0 comments

In the aftermath of Hurricanes Harvey and Irma, a recent news story discussed the mental health consequences of disasters. Researcher Jean Rhodes of University of Massachusetts Boston studied the mental health of young parents living in New Orleans before and after Hurricane Katrina. RISK- Resilience In Survivors of Katrina is the project’s name. An...

Read More

Bevacizumab plus chemotherapy improves outcomes in metastatic colorectal cancer

Posted by on Aug 21, 2017 in Colorectal cancer | 0 comments

In a nutshell This study compared the effectiveness of the combined treatment with chemotherapy and bevacizumab (Avastin) to chemotherapy alone in advanced colorectal cancer. Researchers suggested that the combination therapy improves the treatment of these patients. Some background Colorectal cancer is one of the most common cancers causing death...

Read More

Is targeted chemotherapy for stage II/III rectal cancer before surgery effective?

Posted by on Aug 19, 2017 in Colorectal cancer | 0 comments

In a nutshell This study examined the effect of pre-surgical chemotherapy without radiotherapy in stage II/III rectal cancer. The study showed that combined targeted chemotherapy was effective in these patients. Some background Rectal cancer is a cancer of the end part of the digestive system. In stage II and III, the cancer has begun to...

Read More